June 27, 2026 12:43 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations | Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi | Taratala warehouse collapse: Death toll climbs to 8, five arrested as SIT launches probe | Oil prices crash, IndiGo takes off! Aviation and fuel stocks emerge as biggest winners | Passport is a travel document, not conclusive proof of citizenship: MEA
Image Credit : Photo: File/UNI

Govt asks Patanjali to explain ‘dubious’ transactions flagged by economic intelligence wing

| @indiablooms | May 30, 2025, at 05:10 pm

New Delhi: India’s Corporate Affairs Ministry has issued a notice to Patanjali Ayurved Ltd., the traditional medicine firm co-founded by yoga guru Baba Ramdev, seeking clarification over transactions considered suspicious, Bloomberg reported, citing people familiar with the matter.

The notice followed findings by the federal economic intelligence wing, which identified the transactions as “abnormal and dubious”, the people said, requesting anonymity due to regulatory protocols.

The individuals did not reveal the financial scale of the transactions, noting that the investigation remains at a preliminary stage.

According to them, the company has been granted approximately two months to submit a response.

Authorities will also probe potential breaches of corporate governance and possible diversion of funds, they added.

The Corporate Affairs Ministry did not immediately respond to a request for comment. Patanjali Ayurved has also yet to provide a statement.

This is not the first instance of regulatory scrutiny for Patanjali Ayurved or its subsidiaries.

Last year, one of its units was served show-cause notices by the government over alleged tax defaults and ineligible refund claims.

Separately, India’s Supreme Court barred the company from advertising its products as cures for illnesses such as cancer, citing violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

In February 2025, Kerala’s Drugs Control Department reported 26 active cases across different courts in the state against Ramdev and Patanjali under the same advertisement law.

Several newspapers are also facing legal action for publishing the contentious ads.

While Patanjali Ayurved remains privately held, its listed arm, Patanjali Foods Ltd., has seen its shares fall nearly 10% so far this month.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm